Subsequently, blockade of the biologic activity of the cytokine IL-6 was shown to be an efficient treatment for patients with rheumatoid arthritis and other autoimmune diseases2, and it was shown that blocking IL-6 activity was more efficient than blocking TNFα in a monotherapy trial50. The gene discussed is TNF; the disease is rheumatoid arthritis.